Historical Valuation
Medpace Holdings Inc (MEDP) is now in the Fair zone, suggesting that its current forward PE ratio of 34.74 is considered Fairly compared with the five-year average of 30.15. The fair price of Medpace Holdings Inc (MEDP) is between 501.44 to 654.08 according to relative valuation methord.
Relative Value
Fair Zone
501.44-654.08
Current Price：600.02
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Medpace Holdings Inc (MEDP) has a current Price-to-Book (P/B) ratio of 55.61. Compared to its 3-year average P/B ratio of 24.13 , the current P/B ratio is approximately 130.46% higher. Relative to its 5-year average P/B ratio of 18.44, the current P/B ratio is about 201.62% higher. Medpace Holdings Inc (MEDP) has a Forward Free Cash Flow (FCF) yield of approximately 4.21%. Compared to its 3-year average FCF yield of 4.87%, the current FCF yield is approximately -13.58% lower. Relative to its 5-year average FCF yield of 4.62% , the current FCF yield is about -9.01% lower.
P/B
Median3y
24.13
Median5y
18.44
FCF Yield
Median3y
4.87
Median5y
4.62
Competitors Valuation Multiple
AI Analysis for MEDP
The average P/S ratio for MEDP competitors is 3.35, providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP.O) exhibits a P/S ratio of 5.80, which is 73.41% above the industry average. Given its robust revenue growth of 23.74%, this premium appears sustainable.
Performance Decomposition
AI Analysis for MEDP
1Y
3Y
5Y
Market capitalization of MEDP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MEDP in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is MEDP currently overvalued or undervalued?
Medpace Holdings Inc (MEDP) is now in the Fair zone, suggesting that its current forward PE ratio of 34.74 is considered Fairly compared with the five-year average of 30.15. The fair price of Medpace Holdings Inc (MEDP) is between 501.44 to 654.08 according to relative valuation methord.
What is Medpace Holdings Inc (MEDP) fair value?
MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Medpace Holdings Inc (MEDP) is between 501.44 to 654.08 according to relative valuation methord.
How does MEDP's valuation metrics compare to the industry average?
The average P/S ratio for MEDP's competitors is 3.35, providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP) exhibits a P/S ratio of 5.80, which is 73.41% above the industry average. Given its robust revenue growth of 23.74%, this premium appears sustainable.
What is the current P/B ratio for Medpace Holdings Inc (MEDP) as of Jan 10 2026?
As of Jan 10 2026, Medpace Holdings Inc (MEDP) has a P/B ratio of 55.61. This indicates that the market values MEDP at 55.61 times its book value.
What is the current FCF Yield for Medpace Holdings Inc (MEDP) as of Jan 10 2026?
As of Jan 10 2026, Medpace Holdings Inc (MEDP) has a FCF Yield of 4.21%. This means that for every dollar of Medpace Holdings Inc’s market capitalization, the company generates 4.21 cents in free cash flow.
What is the current Forward P/E ratio for Medpace Holdings Inc (MEDP) as of Jan 10 2026?
As of Jan 10 2026, Medpace Holdings Inc (MEDP) has a Forward P/E ratio of 34.74. This means the market is willing to pay $34.74 for every dollar of Medpace Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Medpace Holdings Inc (MEDP) as of Jan 10 2026?
As of Jan 10 2026, Medpace Holdings Inc (MEDP) has a Forward P/S ratio of 5.80. This means the market is valuing MEDP at $5.80 for every dollar of expected revenue over the next 12 months.